Important Resources · Mind Medicine Australia
Mind Medicine Australia logo Menu

Important Resources

Documents

Mind Medicine Australia Overview

Pioneering a new paradigm for mental health treatment in Australia.

Download (228.7 KB)

Mind Medicine Australia FAQ

Frequently Asked Questions about Mind Medicine Australia and psychedelics.

Download (628.4 KB)

Position Statement on Compassionate Access, November 2022

Mind Medicine Australia recommends that at this time psilocybin and MDMA should be allowed for treatment-resistant patients – psilocybin for depression and MDMA for PTSD – on a compassionate need basis.

Download (236.1 KB)

MMA’s views on the approach of the Royal Australian and New Zealand College of Psychiatrists (RANZCP)

MMA’s views on the approach of the Royal Australian and New Zealand College of Psychiatrists (RANZCP) to the off-label psychiatric use of anaesthetic ketamine compared with its approach to the compassionate use of psilocybin and MDMA.

Download here

What is Psychedelic-Assisted Therapy?

This paper outlines the therapeutic process of psychedelic-assisted therapy and describes the three distinct therapy phases: preparation, the experience and integration.

Download (167.3 KB)

Legal Medicine Centres

A list of legal medicine centres abroad.

Read more

Mental Health Statistics

Some basic numbers relevant to mental illness in Australia

Download (105.3 KB)

Certificate in Psychedelic-Assisted Therapies FAQ

Frequently asked questions about our Certificate in Psychedelic-Assisted Therapies (CPAT).

Download (194.0 KB)

Mind Medicine Australia Fact Sheet

A 2 page infographic outlining key facts and figures about mental health and Mind Medicine Australia.

Download (1.4 MB)

Mind Medicine Australia Ebook

A compilation of our mission, an overview of the mental illness crisis and frequently asked questions.

Download (3.6 MB)

International Psilocybin Trials

A list of current international psilocybin trials.

Download (1.3 MB)

Psychedelic Medical Research

A detailed review of clinical trials registered with a range of organisations around the globe.

Download

List of Drug/Substances and their negative and positive effects

Here's a list outlining the negative and positive effects of each drug subclass.

Download (173.9 KB)

Interactions with other Medicines

Psilocybin and interactions with other medicines.

Download (130.4 KB)

Antidepressant & Psychedelic Drug Interaction Chart

This table outlines the time period required to reduce the intake of antidepressants before administering a psychedelic, in order to maximise its effect.

Download your copy

List of Educational Books and Videos

A collection of books and videos to learn all about psychedelics.

Download (403.6 KB)

Psychedelic Substances Table

An overview of psychedelic substances scheduling in different countries.

Download (163.4 KB)

Psychedelic Timeline

A timeline showing the use of plant medicines from ~5000 BCE to the present.

View timeline

Covid-19 Significant Societal and Mental Health Impacts

Mind Medicine Australia has put together a report documenting Covid-19 Significant Societal and Mental Health Impacts. The report includes: Modelling and Future Predictions, Children and Youth, Mental Health, Unemployment, Domestic and Family Violence, Divorce, Alcohol and Tobacco, Financial Insecurity, Eating Disorders, Refugee and Migrant Issues, Social Media, Hospitalisations and Emergency Department, Crime and Cyber Abuse, Racism, Porn Use

Download (434.2 KB)

Mystical Experiences Questionnaire

.

Download (550.7 KB)

Relative Drug Harms

A study comparing relative drug harms of various substances.

Download (322.0 KB)

FMRI scans comparing psilocybin with the placebo for depression

Increased communication between brain networks shown on fMRI scans.

Download (650.2 KB)

Application of MDMA in PTSD Psychotherapy

Source: Multidisciplinary Association for Psychedelic Studies (MAPS)

Download (315.5 KB)

Psychedelic Research Methodology Overview

Research methodology overview for psychedelic medicine

Download (7.4 MB)

Simple Drug Interactions Chart – Professor David Nutt

Simple Drug Interactions Chart – Professor David Nutt

Download (147.7 KB)

Mind Medicine Australia TGA Rescheduling Submissions

Mind Medicine Australia Submission Guide

Mind Medicine Australia's overview and instruction on how to make your submission to the TGA.

Download (785.5 KB)

Medicinal Psilocybin Rescheduling Application

Mind Medicine Australia's application to reschedule Psilocybine from Schedule 9 to Schedule 8 of the Poisons Standard 14 July 2020.

Download (2.2 MB)

Medicinal MDMA Rescheduling Application

Mind Medicine Australia's application to reschedule N, α-DIMETHYL 3,4(METHYLENEDIOXY) PHENYLETHYLAME (MDMA) from Schedule 9 to Schedule 8 of the Poisons Standard 15 July 2020.

Download (1.8 MB)

Download and Print - Meet With Your GP!

1. Mind Medicine Australia SAS-B TGA Application Form

Mind Medicine Australia SAS-B TGA Application Form

Download (124.3 KB)

2. Mind Medicine Australia MDMA SAS-B Cover Letter Example

Mind Medicine Australia MDMA SAS-B Cover Letter Example

Download (100.1 KB)

3. Mind Medicine Australia MDMA SAS-B Proforma Template

Mind Medicine Australia MDMA SAS-B Proforma Template

Download (1.1 MB)

4. Mind Medicine Australia MDMA SAS-B Patient Information Form

Mind Medicine Australia MDMA SAS-B Patient Information Form

Download (25.2 KB)

5. Mind Medicine Australia Psilocybin SAS-B Cover Letter Example

Mind Medicine Australia Psilocybin SAS-B Cover Letter Example

Download (504.6 KB)

6. Mind Medicine Australia Psilocybin SAS-B Proforma Template

Mind Medicine Australia Psilocybin SAS-B Proforma Template

Download (648.2 KB)

7. Mind Medicine Australia Psilocybin SAS-B Patient Information Form

Mind Medicine Australia Psilocybin SAS-B Patient Information Form

Download (102.6 KB)

Proposed changes to ACT legislation to allow access for treatment-resistant patients in the ACT

1. Mind Medicine Australia briefing note to facilitate approvals in the ACT (March 2022)

The Commonwealth Government's Therapeutic Goods Administration allows treatment-resistant PTSD and treatment-resistant depression patients to receive MDMA assisted psychotherapy for the treatment of PTSD and psilocybin assisted psychotherapy for the treatment of depression. However the interplay of ACT and federal legislation means this cannot occur legally in the ACT. Our briefing note explains the benefits.

Download (630.5 KB)

2. Legal advice from Greg Barns SC details the simple legislative changes in the ACT

Legal advice from Greg Barns SC regarding changes to the ACT framework.

Download (61.6 KB)

Mind Medicine Australia Branding

Logos

MMA logo in various formats

Download (151.4 KB)

Subscribe to our newsletter

Stay in touch with Mind Medicine Australia:

×